Edward J. Dulac III, Chief Financial Officer at FATE THERAPEUTICS INC (FATE), sold 6,885 shares at $87.90 ($608K) on 2021-08-19, disclosed to the SEC on 2021-08-20.
Open-market sale of $608k FATE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.90 | 1,937 | $170K | 28.0% |
| 2 | $87.90 | 1,937 | $170K | 28.0% |
| 3 | $88.65 | 1,474 | $131K | 21.5% |
| 4 | $88.65 | 1,474 | $131K | 21.5% |
| 5 | $90.00 | 63 | $6K | 0.9% |
| Total | $88.24 avg | 6,885 |
| $608K |
| 100% |
| Filing → |
| NTLA | SELL | 2026-01-07 | $59K | — | Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |